StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionJul 6, 2026, 04:18 PM

Agenus Extends $5.09M Notes, Issues New Warrants

AI Summary

Agenus Inc. entered into an amendment with existing noteholders to extend the maturity date of $5.09 million in senior subordinated promissory notes by eight months to February 18, 2027. The company also extended the expiration dates of previously issued 2022 A, 2022 B, and 2025 C Warrants to June 25, 2031. Additionally, Agenus issued new 2026 D Warrants to certain noteholders, allowing them to purchase an aggregate of 56,525 shares of common stock at an exercise price of $3.25 per share, also expiring on June 25, 2031.

Key Highlights

  • Extended maturity of $5.09 million senior subordinated promissory notes by eight months to February 18, 2027.
  • Extended expiration of 2022 A Warrants (65,000 shares) to June 25, 2031.
  • Extended expiration of 2022 B Warrants (32,500 shares) to June 25, 2031.
  • Extended expiration of 2025 C Warrants (67,500 shares) to June 25, 2031.
  • Issued new 2026 D Warrants for 56,525 shares at $3.25 per share, expiring June 25, 2031.
  • Shares underlying new D Warrants to be registered for resale within 90 days.